(Q42994437)

12 November 2017

title

Expression of interferon receptor genes in the liver as a predictor of interferon response in patients with chronic hepatitis C. (English)

1 reference

12 November 2017

Morita K

1

1 reference

12 November 2017

Tanaka K

2

1 reference

12 November 2017

Saito S

3

1 reference

12 November 2017

Kitamura T

4

1 reference

12 November 2017

Kiba T

5

1 reference

12 November 2017

Fujii T

6

1 reference

12 November 2017

Numata K

7

1 reference

12 November 2017

Sekihara H

8

1 reference

12 November 2017

publication date

1 August 1999

1 reference

Journal of Medical Virology

12 November 2017

published in

1 reference

12 November 2017

volume

58

1 reference

12 November 2017

issue

4

1 reference

12 November 2017

page(s)

359-365

1 reference

High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199908%2958%3A4%3C359%3A%3AAID-JMV7%3E3.0.CO%3B2-S

Risk factors and prevention of hepatocellular carcinoma in HCV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199908%2958%3A4%3C359%3A%3AAID-JMV7%3E3.0.CO%3B2-S

Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199908%2958%3A4%3C359%3A%3AAID-JMV7%3E3.0.CO%3B2-S

Prediction of response to interferon treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199908%2958%3A4%3C359%3A%3AAID-JMV7%3E3.0.CO%3B2-S

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199908%2958%3A4%3C359%3A%3AAID-JMV7%3E3.0.CO%3B2-S

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199908%2958%3A4%3C359%3A%3AAID-JMV7%3E3.0.CO%3B2-S

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199908%2958%3A4%3C359%3A%3AAID-JMV7%3E3.0.CO%3B2-S

Effectiveness of interferon-alpha therapy in chronic hepatitis C is associated with the amount of interferon-alpha receptor mRNA in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199908%2958%3A4%3C359%3A%3AAID-JMV7%3E3.0.CO%3B2-S

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199908%2958%3A4%3C359%3A%3AAID-JMV7%3E3.0.CO%3B2-S

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199908%2958%3A4%3C359%3A%3AAID-JMV7%3E3.0.CO%3B2-S

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199908%2958%3A4%3C359%3A%3AAID-JMV7%3E3.0.CO%3B2-S

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199908%2958%3A4%3C359%3A%3AAID-JMV7%3E3.0.CO%3B2-S

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199908%2958%3A4%3C359%3A%3AAID-JMV7%3E3.0.CO%3B2-S

Expression of interferon receptor genes (IFNAR1 and IFNAR2 mRNA) in the liver may predict outcome after interferon therapy in patients with chronic genotype 2a or 2b hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199908%2958%3A4%3C359%3A%3AAID-JMV7%3E3.0.CO%3B2-S

The human interferon alpha/beta receptor: characterization and molecular cloning

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199908%2958%3A4%3C359%3A%3AAID-JMV7%3E3.0.CO%3B2-S

Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199908%2958%3A4%3C359%3A%3AAID-JMV7%3E3.0.CO%3B2-S

Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon α2a therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199908%2958%3A4%3C359%3A%3AAID-JMV7%3E3.0.CO%3B2-S

Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199908%2958%3A4%3C359%3A%3AAID-JMV7%3E3.0.CO%3B2-S

Quantitative analysis of interferon alpha/beta receptor mRNA in the liver of patients with chronic hepatitis C: correlation with serum hepatitis C virus-RNA levels and response to treatment with interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199908%2958%3A4%3C359%3A%3AAID-JMV7%3E3.0.CO%3B2-S

Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199908%2958%3A4%3C359%3A%3AAID-JMV7%3E3.0.CO%3B2-S

Interferon for non-A, non-B chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199908%2958%3A4%3C359%3A%3AAID-JMV7%3E3.0.CO%3B2-S

Specific high-affinity binding of 125I-labeled mouse interferon to interferon resistant embryonal carcinoma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199908%2958%3A4%3C359%3A%3AAID-JMV7%3E3.0.CO%3B2-S

A classification of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199908%2958%3A4%3C359%3A%3AAID-JMV7%3E3.0.CO%3B2-S

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199908%2958%3A4%3C359%3A%3AAID-JMV7%3E3.0.CO%3B2-S

The synergistic effect of human recombinant interferon-alpha 2a in combination with interferon-gamma and the induction of interferon-alpha 2a receptor by interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199908%2958%3A4%3C359%3A%3AAID-JMV7%3E3.0.CO%3B2-S

10.1002/(SICI)1096-9071(199908)58:4<359::AID-JMV7>3.0.CO;2-S

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference